[1]叶章群,邓耀良. 泌尿系结石诊断治疗指南[M]//黄健,王建业,孔垂泽,等. 中国泌尿外科和男科疾病诊断治疗指南(2019版). 北京: 科学出版社, 2020: 237-267. [2]Sasaki Y, Kohjimoto Y, Iba A, et al. Weight loss intervention reduces the risk of kidney stone formation in a rat model of metabolic syndrome[J]. Int J Urol, 2015, 22: 404-409. [3]Tae BS, Balpukov U, Cho SY, et al. Eleven-year cumulative incidence and estimated lifetime prevalence of urolithiasis in Korea: a national health insurance service-national sample cohort based study[J]. J Korean Med Sci, 2018, 33: e13. doi: 10.3346/jkms.2018.33.e13. [4]Nerli R, Jali M, Guntaka AK, et al. Type 2 diabetes mellitus and renal stones[J]. Adv Biomed Res, 2015, 4: 180-184. [5]Chu FY, Chang CC, Huang PH, et al. The association of uric acid calculi with obesity, prediabetes, type 2 diabetes mellitus, and hypertension[J]. Biomed Res Int, 2017, 2017: 7523960.doi:10.1155/2017/7523960. [6]Cohen AJ, Adamsky MA, Nottingham CU, et al. Impact of statin intake on kidney stone formation[J]. Urology, 2019, 124: 57-61. [7]Masterson JH, Woo JR, Chang DC, et al. Dyslipidemia is associated with an increased risk of nephrolithiasis[J]. Urolithiasis, 2015, 43: 49-53. [8]Kohjimoto Y, Sasaki Y, Iguchi M, et al. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan[J]. Am J Kidney Dis, 2013, 61: 923-929. [9]Carbone A, Al Salhi Y, Tasca A, et al. Obesity and kidney stone disease: a systematic review[J]. Minerva Urol Nefrol, 2018, 70: 393-400. [10]Eisner BH, Porten SP, Bechis SK, et al. Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone form ers[J]. J Urol, 2010, 183: 2244-2248. [11]Taylor EN, Mount DB, Forman JP, et al. Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors[J]. Am J Kidney Dis, 2006, 47: 780-789. [12]Rams K, Philipraj SJ, Purwar R, et al. Correlation of metabolic syndrome and urolithiasis: a prospective cross-sectional study[J]. Urol Ann, 2020, 12: 144-149. |